Bosentan Kern Pharma shortage status
1 active shortage notice across 1 country.
Last updated 1 Nov 2026 · sourced from official medicines regulators
- Generic name (INN)
- Bosentan Kern Pharma
- Class
- Auto-created by Agencia Española de Medicamentos — Problemas de Suministro scraper
Where Bosentan Kern Pharma is in shortage
Why Bosentan Kern Pharma is in shortage
- supply-chain disruption — e.g. “Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.” (Spain)
Frequently asked questions
Is Bosentan Kern Pharma currently in shortage?
Yes. As of the latest regulator updates, Bosentan Kern Pharma has 1 active shortage notice across 1 country (Spain). Status is refreshed daily from official regulatory sources.
Why is Bosentan Kern Pharma in shortage?
Regulators attribute the current Bosentan Kern Pharma shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Bosentan Kern Pharma shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Bosentan Kern Pharma status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.